CION Ameerpet
Pancreatic Cancer · Diagnosis & Tests · Reviewed by CION Oncologists
Vascular involvement in pancreatic cancer — what the scan is actually saying
A pancreatic scan report rarely says operable or not. It says the tumour abuts, contacts or encases a named vessel — the SMA, the SMV, the portal vein — and leaves you to work out the rest. This page translates those sentences, one vessel at a time.
- It is an anatomy statement — not a stage, not evidence of spread, and not a prognosis.
- Veins and arteries are not equal — a vein segment can often be rebuilt; an artery rarely can.
- The words are graded — contact, abutment and encasement describe different amounts of the same thing.
- The category can change — treatment first moves some tumours back towards an operation.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres Across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Start here
What Your Report Means by “Vascular Involvement”
A radiology report almost never uses the word operable. It says something narrower and colder: tumour abuts the superior mesenteric vein over a short segment, or solid tumour contact with the coeliac axis. Those sentences are written for a surgeon and an oncologist, not for the person holding the paper. They are also the sentences that decide the order in which your treatment happens, which is why they are worth understanding properly rather than guessing at.
This page is about the vascular involvement pancreatic cancer teams assess on a dedicated scan — which vessels get named, what each phrase means, and what each one changes. The pancreas sits directly on top of the abdomen's main plumbing. The head of the gland curls around the point where two large veins join. A major artery to the bowel runs immediately behind its neck. The arteries to the liver, stomach and spleen branch off just above it. Because of that geography, a pancreatic tumour does not have to be large or aggressive to sit against a vessel. Proximity here is anatomy, not a measure of how bad the cancer is.
What the radiologist is grading is how much of the vessel wall the tumour is in contact with, and whether the vessel itself has changed shape. Contact or abutment means the tumour touches part of the way around the circumference with no fat plane in between. Encasement means it wraps more than half of the way around. Beyond that, the report may describe the vessel being narrowed, pulled into an irregular teardrop shape, or blocked altogether with small new veins opening up around the blockage. Each of those is a different finding with a different consequence.
The single most useful distinction is between arteries and veins. A short segment of an involved vein can often be removed together with the tumour and rebuilt. An artery is a much harder problem, because the bowel and the liver depend on it, and because pancreatic tumours tend to travel along the nerve tissue that wraps around those arteries. None of this can be judged on an ordinary abdominal scan. It needs the timed, thin-slice study described in the pancreatic-protocol CT scan.
Did you know? NCCN guidance on pancreatic adenocarcinoma sorts a newly diagnosed tumour into resectable, borderline resectable, locally advanced or metastatic disease almost entirely on vessel anatomy — and it names the vessels. On the arterial side: the superior mesenteric artery, the coeliac axis and the common hepatic artery. On the venous side: the superior mesenteric vein and the portal vein. The category turns on how much of each vessel's circumference the tumour touches and, for a vein, on whether the involved segment could be reconstructed. That is also why the same tumour can be described differently at two hospitals when only one of them used a dedicated pancreatic-protocol scan with the right contrast timing and thin slices — and why NCCN asks for that scan, reviewed by a multidisciplinary team, before anyone commits to a plan.
Vessel by vessel
The Vessels Your Report Names, and Why Each One Matters
A handful of vessels do almost all of the work in a pancreatic report. Knowing which one has been named tells you most of what the sentence means.
SMA
The superior mesenteric artery
It runs directly behind the neck of the pancreas and supplies most of the small bowel. It is the vessel that matters most. Contact along part of its circumference usually puts a tumour in the borderline column; a tumour wrapped more than half the way around it usually does not.
Coeliac axis
The coeliac trunk
The first large branch off the aorta, feeding the stomach, liver and spleen. It matters most for tumours in the body and tail of the gland, which sit directly underneath it. A small number of very selected operations can take part of it, and those are performed only by specialist hepatobiliary teams.
Hepatic artery
The common hepatic artery
The route by which blood reaches the liver. A short length of contact that does not extend into the coeliac axis or the point where the artery divides is often reconstructable, which is why a good report says exactly where along the vessel the contact sits, not merely that it exists.
SMV
The superior mesenteric vein
The main vein draining the small bowel, running upward through the tumour's neighbourhood. Venous contact on its own rarely rules out an operation. What is looked at far more closely is the vein's contour — whether it is still round, or squeezed out of shape.
Portal vein
The portal vein and the confluence
The superior mesenteric vein and the splenic vein meet behind the neck of the pancreas to form the portal vein. Involvement at that junction is the commonest venous finding in tumours of the head. A segment can often be removed and rebuilt, in theatre, by partner hepatobiliary surgeons.
Collaterals
New veins that have opened up
When a vein narrows slowly, small collateral veins open around the blockage. Their presence tells you the obstruction is not new, and it makes a clean reconstruction much harder. It is one reason a scan reported as locally advanced pancreatic cancer may stay that way.
Translating the sentence
What Each Phrase on the Report Usually Implies
These are general patterns, not rules. Your own report is read alongside your bloods, your biopsy and your fitness before anything is decided.
| What the report says | What it describes | What it usually means for surgery | Where that call is made |
|---|---|---|---|
| Fat plane preserved | A clear rim of fat still separates the tumour from every named vessel | Usually the resectable column; an operation is considered first, with systemic treatment around it | CION tumour board, reading the protocol CT |
| Abuts, or contact with a vein | The tumour touches part of the way around the superior mesenteric or portal vein, contour still normal | An operation is often still possible; a short venous segment may be taken and rebuilt | Planned with the partner hepatobiliary surgical team |
| Deformity, narrowing or teardrop contour | The vein has been pushed out of its normal round shape where the tumour presses on it | Usually borderline territory; reconstruction is planned in advance rather than improvised | Planned with the partner hepatobiliary surgical team |
| Occlusion with collateral veins | The vein is blocked and small new veins have opened around the blockage | Usually moves the plan to systemic treatment first, with reassessment later | CION medical oncology, with the tumour board |
| Contact with the SMA or coeliac axis | Solid tumour touching part of the way around an artery, without wrapping it | Usually borderline resectable; treatment almost always starts before any operation | CION, in-house |
| Encasement of the SMA or coeliac axis | The tumour wraps more than half of the way around the artery | Usually locally advanced rather than metastatic; the aim becomes control, with reassessment | CION, in-house |
| Aortic involvement or distant nodes | Disease reaching beyond the local vessel picture altogether | Surgery is not the tool here; systemic treatment leads and supportive care runs alongside | CION, in-house |
If your report puts you between the columns, the page to read next is borderline resectable pancreatic cancer and what happens next. Bring the discs and the full report, not the summary letter. Book a free consultation or call 1800 202 8726.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A Vessel Sentence Changes the Order of Treatment, Not Whether It Exists
Have the imaging read properly before anyone decides what is and is not possible.
What actually happens
From One Sentence on a Report to an Actual Plan
-
The right scan, done the right way
Vessel contact can only be judged on a timed, thin-slice study of the pancreas, not on a routine abdominal scan. If the first scan was not done to that protocol, we usually repeat it — the detail is set out in the pancreatic-protocol CT scan.
In-house at CION -
The vessels are reported one by one
A good pancreatic report does not simply say the tumour lies close to the vessels. It names each artery and each vein in turn, describes how far around it the contact runs, and says whether the vein has kept its shape.
In-house at CION -
A resectability category is set at the tumour board
The imaging is read together with the biopsy, the CA 19-9 trend, your general fitness and any other disease found. Anatomy leads, but it does not decide alone. That category is what the rest of the plan is built on.
In-house at CION -
Where a vessel is involved, treatment usually starts before surgery
Systemic treatment first, sometimes followed by chemoradiation or stereotactic radiotherapy, is the usual route. All of that is delivered in-house across 35+ centres; the full set of options is laid out in pancreatic cancer treatment in Hyderabad.
In-house at CION -
Restaging — and why the scan may look almost unchanged
After treatment the contact often still appears on CT, because scar tissue around a treated tumour looks much like tumour. The decision is made on the whole picture rather than the scan alone — explained further in borderline resectable pancreatic cancer.
In-house at CION -
If an operation goes ahead, partner surgeons perform it
CION does not run a hepatobiliary theatre, and we would rather say that plainly than blur it. Resection, including removing and rebuilding a segment of vein, is arranged with the specialist partner team at their hospital, and that part of your care may be billed there.
Coordinated with partner HPB / GI surgeons
Worth saying plainly
Three Things Vessel Involvement Does Not Mean
It is not the same as the cancer having spread. A tumour growing against the vein beside it is doing what a tumour in that position does: growing locally, into its immediate neighbour. Spread means deposits somewhere else entirely — the liver, the lining of the abdomen, the lungs. Those are two separate questions with two separate answers, and a scan can say yes to the first and no to the second. Plenty of people whose reports read alarmingly still have disease confined to the pancreas and the tissue around it.
It is not a permanent verdict. A category assigned on the day of diagnosis describes the tumour as it is that week. Borderline disease, and some disease described as locally advanced, is deliberately reassessed after a course of systemic treatment, and for some people the operation that was off the table at the start comes back onto it. That is a real route rather than false hope — and it is also not a promise, which is why the reassessment is scheduled rather than assumed.
It is not a prognosis. Published survival figures for pancreatic cancer average very different situations together: resectable and locally advanced disease, treated and untreated, adenocarcinoma mixed with neuroendocrine tumours that behave far more slowly. No such figure describes the person sitting in front of us, and we will not quote one at you. What can honestly be discussed is your own category, what would have to change to move it, and what the next scan is looking for.
One practical point. Almost everything on this page depends on a report you may not have been handed a copy of. Ask for the full radiology report and the images themselves, not the discharge summary. A specialist can read the vessel sentences directly and tell you where you actually stand, usually in a single sitting.
Being straight about it
What CION Does, and What Is Coordinated Elsewhere
This matters practically, because it decides where you travel and who invoices you. CION does not perform pancreatic surgery. Every pancreatic resection, including removal and reconstruction of a segment of vein and the rare arterial work, along with staging laparoscopy, endoscopic ultrasound and biopsy, ERCP and any biliary or duodenal stent, and coeliac plexus block for pain, is coordinated with specialist hepatobiliary, gastroenterology and endoscopy partner teams, carried out at their hospital, and may be billed there. PET-CT, receptor imaging and receptor-targeted radionuclide therapy are coordinated with partner nuclear-medicine centres.
What happens at CION is everything around the operation, and on a pancreatic pathway that is most of the journey. Ordering and reporting the pancreatic-protocol CT and MRI with MRCP, CA 19-9 and routine bloods. The tumour board that reads the vessels and sets the resectability category. Chemotherapy before or after surgery, maintenance and immune-based systemic treatment where the tumour's genetics support it, radiation, chemoradiation and stereotactic radiotherapy, delivered in-house across 35+ centres. Genetic counselling where the family history warrants it, nutrition and pancreatic enzyme support, pain and psycho-oncology care, and long-term follow-up once treatment settles.
The thing worth holding on to is this. A vessel sentence changes the order of your treatment. It does not decide whether treatment exists, and it is not the last word on whether an operation will ever be possible.
- A free 45-minute consultation, with your scans opened and read in front of you rather than summarised back to you from a report.
- A straight answer on which resectability category your imaging puts you in, and exactly what would have to change to move it.
- A repeat pancreatic-protocol study where the first scan cannot answer the vessel question properly, rather than a decision taken on inadequate imaging.
- A written split of what a partner hospital would bill and what CION bills, agreed before anything is booked.
- Aarogyasri, NTR Vaidya Seva and insurance routes checked against each part of the pathway, not only the treatment at the end of it.
- Systemic treatment, radiation, nutrition and supportive care delivered in-house — the options are set out in pancreatic cancer treatment in Hyderabad, and the whole picture sits in our complete guide to pancreatic cancer.
Bring the scan discs, the full radiology report and the biopsy result if you have one. Those three together are usually enough for a specialist to tell you where you stand and what the next step should be. Book a free consultation or call 1800 202 8726.
Take the next step
Ask What Would Have to Change
The useful question is never only what the scan says today. It is what the next scan is looking for.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Vascular involvement in pancreatic cancer - your questions answered
What does it mean when my scan says the tumour abuts the portal vein?
Abuts, or contact, means the tumour is touching part of the way around the vessel with no rim of fat between the two. On its own, venous contact rarely rules out an operation. What the surgical team looks at next is the vein's contour: if it is still round and open along that segment, the situation is usually more favourable than if it has been squeezed into an irregular or teardrop shape. Where a short length of vein is involved, it can often be removed together with the tumour and the vein rebuilt during the same operation. That work is done by specialist hepatobiliary surgeons at a partner hospital, planned in advance from the imaging rather than decided in theatre.
Is vascular involvement the same as the cancer having spread?
No, and this is the most common misreading of a pancreatic report. Vessel involvement describes local growth: the tumour is pressing against or growing into a blood vessel that happens to lie right beside the pancreas. Spread, or metastasis, means deposits of cancer somewhere else entirely, most often the liver, the lining of the abdomen or the lungs. A scan can show clear vessel contact and no metastatic disease at all, and that combination is common. The two findings are reported separately and they lead to different plans, so it is worth reading the report as two answers rather than one verdict.
Why does artery involvement matter more than vein involvement?
There are two reasons. First, the arteries behind the pancreas carry the entire blood supply to the small bowel and the liver, so they cannot simply be removed and replaced the way a segment of vein often can. Second, pancreatic tumours tend to travel along the nerve tissue that wraps around those arteries, which means arterial contact often signals disease extending further than the visible edge of the tumour. That is why guidance treats a tumour touching part of an artery differently from one wrapped more than half the way around it, and why arterial encasement usually moves treatment towards systemic therapy first rather than straight to an operation.
Can a vein really be removed and rebuilt during pancreatic surgery?
Yes. Where the superior mesenteric vein or the portal vein is involved over a limited length, the affected segment can be resected along with the tumour and the vein reconstructed, either by joining the two ends directly or by bridging the gap with a graft. It is established practice in high-volume hepatobiliary units, and it is planned from the scan before the day of surgery rather than improvised. It does add complexity, which is one reason the imaging is reviewed so carefully first. CION does not perform this surgery: it is coordinated with specialist partner teams and carried out at their hospital, and that part of the care may be billed there.
My scan still shows the same vessel contact after chemotherapy. Has the treatment failed?
Not necessarily, and this is one of the most misleading moments in the whole pathway. After systemic treatment, the tissue immediately around a pancreatic tumour becomes scarred, and on a CT that scar looks very much like tumour. So the contact frequently appears unchanged even where the cancer has responded. Because of that, the decision after treatment is not made on the scan alone. Your team weighs the CA 19-9 trend, your weight and appetite, how you have tolerated treatment, and the surgeon's own reading of the images. People whose scans looked static at restaging have still gone on to have an operation.
Two reports describe my tumour differently. Which one is right?
This happens often, and it usually comes down to the scan rather than the radiologist. Vessel involvement can only be judged properly on a dedicated pancreatic-protocol study, with contrast timed to show the arteries and the veins in separate phases and thin slices through the gland. A routine abdominal scan done for another reason cannot answer the question reliably, and a report based on one will often differ from a report based on a protocol study. Where the two disagree, the usual step is to repeat the imaging correctly and have it reviewed by a multidisciplinary team, rather than choose between two reports.
What does CION do for someone whose scan shows vascular involvement, and what happens at the first visit?
The first visit is a free 45-minute consultation. Bring the scan discs, the full radiology report and the biopsy result if you have one. A medical oncologist opens the images rather than reading a summary letter, goes through the vessel findings with you, and tells you which resectability category they place you in and what would have to change to move it. If the imaging cannot answer the vessel question, we repeat it to protocol. From there, CION delivers the systemic treatment, radiation, chemoradiation and stereotactic radiotherapy, nutrition and enzyme support, pain relief and follow-up in-house across 35+ centres. Any operation, endoscopic procedure or stent is coordinated with specialist partner teams and may be billed there, and we set that split out in writing before anything is booked.
Medical disclaimer: This page explains how vessel involvement is described on pancreatic imaging and how it shapes the treatment sequence, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and not a reading of your own scan; whether an operation is possible depends on your imaging, pathology and fitness, and must be decided with your treating team. Pancreatic-protocol CT, MRI and MRCP, CA 19-9 and bloods ordered and reported, the tumour-board resectability assessment, chemotherapy, maintenance and immune-based systemic treatment, radiation, chemoradiation and SBRT, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain, psycho-oncology and survivorship care are delivered by CION. All pancreatic surgery, including venous resection and reconstruction, staging laparoscopy, endoscopic ultrasound and biopsy, ERCP and biliary or duodenal stenting and coeliac plexus block are coordinated with specialist hepatobiliary, gastroenterology and endoscopy partner centres, and PET-CT, DOTATATE PET and PRRT with partner nuclear-medicine centres; each of these may be billed there.